A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach

Author:

Nannini Margherita1ORCID,Dondi Giulia2,Santini Donatella3,De Leo Antonio3,Dei Tos Angelo Paolo45,Zamagni Claudio6,Saponara Maristella1ORCID,Gatto Lidia1,Nigro Concetta1,Bertaccini Paola7,Zompatori Maurizio7,De Iaco Pierandrea2,Perrone Anna Myriam2,Pantaleo Maria Abbondanza18

Affiliation:

1. Department of Specialized, Experimental and Diagnostic Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

2. Gynecologic Oncology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy

3. Pathology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy

4. Department of Pathology, Azienda ULSS 2 Marca Trevigiana, Treviso, Italy

5. Department of Medicine, School of Medicine, University of Padua, Padua, Italy

6. SSD Oncologia Medica “Addarii,” S. Orsola-Malpighi Hospital, Bologna, Italy

7. Radiology Unit, Cardio-Thoracic-Vascular Department, S. Orsola-Malpighi University Hospital, Bologna, Italy

8. “Giorgio Prodi” Cancer Research Center, University of Bologna, Bologna, Italy

Abstract

Adenosarcomas are the rarest form of uterine sarcomas, and clinical experience with their management is still limited. Here, we reported 7 patients with uterine adenosarcoma referred to our institution, focusing on main pathologic features, their medical history, and long-term follow-up. Among these patients, we provided a detailed description of the medical history of a 49-year-old woman with advanced uterine adenosarcoma with sarcomatous overgrowth who presented a brilliant radiologic and pathologic response after 3 cycles of epirubicin and ifosfamide, ultimately achieving an extraordinary long-term outcome through an integrated surgical and medical approach. Our single-centre experience would suggest that aggressive uterine adenosarcomas with sarcomatous overgrowth are sensitive to standard epirubicin and ifosfamide and that an integrated approach, both medical and surgical, could be considered in clinical practice, again emphasizing the relevant role of multidisciplinary management for this extremely rare disease.

Publisher

SAGE Publications

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3